{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:36:48Z","timestamp":1762425408848,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen Science and Technology Project","award":["JCYJ20220530152406015"],"award-info":[{"award-number":["JCYJ20220530152406015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03068-7","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:05:21Z","timestamp":1760335521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the crucial role of IGF2BP3 in modulating stemness traits of salivary adenoid cystic carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Hongliang","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"3068_CR1","first-page":"197","volume":"84","author":"P Castelnuovo","year":"2020","unstructured":"Castelnuovo P, Turri-Zanoni M. Adenoid cystic carcinoma. Adv Otorhinolaryngol. 2020;84:197\u2013209.","journal-title":"Adv Otorhinolaryngol"},{"key":"3068_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.14639\/0392-100X-N1379","volume":"41","author":"G Cantu","year":"2021","unstructured":"Cantu G. Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis. Acta Otorhinolaryngol Ital. 2021;41:206\u201314.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"3068_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11864-022-01001-y","volume":"23","author":"LG de Sousa","year":"2022","unstructured":"de Sousa LG, Jovanovic K, Ferrarotto R. Metastatic adenoid cystic carcinoma: genomic landscape and emerging treatments. Curr Treat Options Oncol. 2022;23:1135\u201350.","journal-title":"Curr Treat Options Oncol"},{"key":"3068_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105945","volume":"130","author":"Y Fang","year":"2022","unstructured":"Fang Y, Peng Z, Wang Y, Gao K, Liu Y, Fan R, et al. Current opinions on diagnosis and treatment of adenoid cystic carcinoma. Oral Oncol. 2022;130:105945.","journal-title":"Oral Oncol"},{"key":"3068_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105213","volume":"115","author":"L Lorini","year":"2021","unstructured":"Lorini L, Ardighieri L, Bozzola A, Romani C, Bignotti E, Buglione M, et al. Prognosis and management of recurrent and\/or metastatic head and neck adenoid cystic carcinoma. Oral Oncol. 2021;115:105213.","journal-title":"Oral Oncol"},{"key":"3068_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47\u201376.","journal-title":"Annu Rev Pathol"},{"key":"3068_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple RC, Yang K, Halbert ME, Agnihotri S, Rich JN. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer. 2022;22:497\u2013514.","journal-title":"Nat Rev Cancer"},{"key":"3068_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.arcmed.2022.11.012","volume":"53","author":"H Mayani","year":"2022","unstructured":"Mayani H, Chavez-Gonzalez A, Vazquez-Santillan K, Contreras J, Guzman ML. Cancer stem cells: biology and therapeutic implications. Arch Med Res. 2022;53:770\u201384.","journal-title":"Arch Med Res"},{"key":"3068_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21:60.","journal-title":"Mol Cancer"},{"key":"3068_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA n6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res. 2020;39:203.","journal-title":"J Exp Clin Cancer Res"},{"key":"3068_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.962204","volume":"12","author":"Z Guo","year":"2022","unstructured":"Guo Z, Zhang X, Lin C, Huang Y, Zhong Y, Guo H, et al. METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification. Front Oncol. 2022;12:962204.","journal-title":"Front Oncol"},{"key":"3068_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100503","volume":"17","author":"X Xu","year":"2022","unstructured":"Xu X, Cui J, Wang H, Ma L, Zhang X, Guo W, et al. IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Mater Today Bio. 2022;17:100503.","journal-title":"Mater Today Bio"},{"key":"3068_CR13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer. Cancer Res. 2023;83:2187\u2013207.","journal-title":"Cancer Res"},{"key":"3068_CR14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200751RR","volume":"36","author":"T Jiang","year":"2022","unstructured":"Jiang T, He X, Zhao Z, Zhang X, Wang T, Jia L. RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression. FASEB J. 2022;36:e22618.","journal-title":"FASEB J"},{"key":"3068_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s12276-023-00957-7","volume":"55","author":"MJ Zhou","year":"2023","unstructured":"Zhou MJ, Yang JJ, Ma TY, Feng GX, Wang XL, Wang LY, et al. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway. Exp Mol Med. 2023;55:597\u2013611.","journal-title":"Exp Mol Med"},{"key":"3068_CR16","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1111\/jcmm.16003","volume":"24","author":"W Huang","year":"2020","unstructured":"Huang W, Li Y, Zhang C, Zha H, Zhou X, Fu B, et al. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer. J Cell Mol Med. 2020;24:13949\u201360.","journal-title":"J Cell Mol Med"},{"key":"3068_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-021-01480-x","volume":"21","author":"YZ Yu","year":"2022","unstructured":"Yu YZ, Lv DJ, Wang C, Song XL, Xie T, Wang T, et al. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Mol Cancer. 2022;21:12.","journal-title":"Mol Cancer"},{"key":"3068_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2174\/0929867329666220614091445","volume":"30","author":"A Yan","year":"2023","unstructured":"Yan A, Song X, Liu B, Zhu K. IGF2BP3 worsens lung cancer through modifying long non-coding RNA CERS6-AS1\/microRNA-1202 axis. Curr Med Chem. 2023;30:878\u201391.","journal-title":"Curr Med Chem"},{"key":"3068_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119542","author":"X Jing","year":"2023","unstructured":"Jing X, Han C, Li Q, Li F, Zhang J, Jiang Q, et al. IGF2BP3-EGFR-AKT axis promotes breast cancer MDA-MB-231 cell growth. Biochim Biophys Acta. 2023. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119542.","journal-title":"Biochim Biophys Acta"},{"key":"3068_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4217259","volume":"2018","author":"J Cao","year":"2018","unstructured":"Cao J, Mu Q, Huang H. The roles of insulin-like growth factor 2 mRNA-binding protein 2 in cancer and cancer stem cells. Stem Cells Int. 2018;2018:4217259.","journal-title":"Stem Cells Int"},{"key":"3068_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.32604\/or.2022.026511","volume":"30","author":"X Li","year":"2022","unstructured":"Li X, Wang Q, Liang H, Chen S, Chen H, Lu Y, et al. IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells. Oncol Res. 2022;30:77\u201387.","journal-title":"Oncol Res"},{"key":"3068_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/hep.31850","volume":"74","author":"WB Ding","year":"2021","unstructured":"Ding WB, Wang MC, Yu J, Huang G, Sun DP, Liu L, et al. HBV\/pregenomic RNA increases the stemness and promotes the development of HBV-related HCC through reciprocal regulation with insulin-like growth factor 2 mRNA-binding protein 3. Hepatology. 2021;74:1480\u201395.","journal-title":"Hepatology"},{"key":"3068_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/onc.2015.164","volume":"35","author":"S Samanta","year":"2016","unstructured":"Samanta S, Sun H, Goel HL, Pursell B, Chang C, Khan A, et al. IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG. Oncogene. 2016;35:1111\u201321.","journal-title":"Oncogene"},{"key":"3068_CR24","first-page":"2688","volume":"22","author":"QD Huang","year":"2018","unstructured":"Huang QD, Zheng SR, Cai YJ, Chen DL, Shen YY, Lin CQ, et al. IMP3 promotes TNBC stem cell property through miRNA-34a regulation. Eur Rev Med Pharmacol Sci. 2018;22:2688\u201396.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3068_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02466-3","volume":"41","author":"Q Ma","year":"2022","unstructured":"Ma Q, Yang F, Huang B, Pan X, Li W, Yu T, et al. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex. J Exp Clin Cancer Res. 2022;41:251.","journal-title":"J Exp Clin Cancer Res"},{"key":"3068_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI80046","volume":"126","author":"JK Palanichamy","year":"2016","unstructured":"Palanichamy JK, Tran TM, Howard JM, Contreras JR, Fernando TR, Sterne-Weiler T, et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Invest. 2016;126:1495\u2013511.","journal-title":"J Clin Invest"},{"key":"3068_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0557","author":"J Tang","year":"2023","unstructured":"Tang J, Wang S, Weng M, Guo Q, Ren L, He Y, et al. The IGF2BP3-COPS7B axis facilitates mRNA translation to drive colorectal cancer progression. Cancer Res. 2023. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0557.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03068-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03068-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03068-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:33:45Z","timestamp":1762425225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03068-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03068-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"513"}}